Correction: To Mars and beyond. Space exploration and space medicine in Leukemia

Robert Peter Gale,Andreas Hochhaus

DOI: https://doi.org/10.1038/s41375-024-02324-5

2024-06-26

Leukemia

Abstract:Leukemia, Published online: 25 June 2024; doi:10.1038/s41375-024-02324-5 Correction: To Mars and beyond. Space exploration and space medicine in Leukemia

oncology,hematology

What problem does this paper attempt to address?

To Mars and beyond. Space exploration and space medicine in Leukemia

R. P. Gale,Andreas Hochhaus

DOI: https://doi.org/10.1038/s41375-024-02286-8

2024-05-23

Leukemia

Abstract:Leukemia, Published online: 22 May 2024; doi:10.1038/s41375-024-02286-8 To Mars and beyond. Space exploration and space medicine in Leukemia

oncology,hematology
Author Correction: Decade-long leukaemia remissions with persistence of CD4 + CAR T cells

J. Joseph Melenhorst,Gregory M. Chen,Meng Wang,David L. Porter,Changya Chen,McKensie A. Collins,Peng Gao,Shovik Bandyopadhyay,Hongxing Sun,Ziran Zhao,Stefan Lundh,Iulian Pruteanu-Malinici,Christopher L. Nobles,Sayantan Maji,Noelle V. Frey,Saar I. Gill,Alison W. Loren,Lifeng Tian,Irina Kulikovskaya,Minnal Gupta,David E. Ambrose,Megan M. Davis,Joseph A. Fraietta,Jennifer L. Brogdon,Regina M. Young,Anne Chew,Bruce L. Levine,Donald L. Siegel,Cécile Alanio,E. John Wherry,Frederic D. Bushman,Simon F. Lacey,Kai Tan,Carl H. June

DOI: https://doi.org/10.1038/s41586-022-05376-8

IF: 64.8

2022-12-08

Nature

Abstract:Nature - Author Correction: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells

multidisciplinary sciences
Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases10 (2023) 1367–1401]

Uttpal Anand,Abhijit Dey,Arvind K Singh Chandel,Rupa Sanyal,Amarnath Mishra,Devendra Kumar Pandey,Valentina De Falco,Arun Upadhyay,Ramesh Kandimalla,Anupama Chaudhary,Jaspreet Kaur Dhanjal,Saikat Dewanjee,Jayalakshmi Vallamkondu,José M Pérez de la Lastra,Arvind K. Singh Chandel,José M. Pérez de la Lastra

DOI: https://doi.org/10.1016/j.gendis.2024.101211

IF: 7.376

2024-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2022.02.007.].

genetics & heredity,biochemistry & molecular biology
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Nimitha R Mathew,Francis Baumgartner,Lukas Braun,David O'Sullivan,Simone Thomas,Miguel Waterhouse,Tony A Müller,Kathrin Hanke,Sanaz Taromi,Petya Apostolova,Anna L Illert,Wolfgang Melchinger,Sandra Duquesne,Annette Schmitt-Graeff,Lena Osswald,Kai-Li Yan,Arnim Weber,Sonia Tugues,Sabine Spath,Dietmar Pfeifer,Marie Follo,Rainer Claus,Michael Lübbert,Christoph Rummelt,Hartmut Bertz,Ralph Wäsch,Johanna Haag,Andrea Schmidts,Michael Schultheiss,Dominik Bettinger,Robert Thimme,Evelyn Ullrich,Yakup Tanriver,Giang Lam Vuong,Renate Arnold,Philipp Hemmati,Dominik Wolf,Markus Ditschkowski,Cordula Jilg,Konrad Wilhelm,Christian Leiber,Sabine Gerull,Jörg Halter,Claudia Lengerke,Thomas Pabst,Thomas Schroeder,Guido Kobbe,Wolf Rösler,Soroush Doostkam,Stephan Meckel,Kathleen Stabla,Stephan K Metzelder,Sebastian Halbach,Tilman Brummer,Zehan Hu,Joern Dengjel,Björn Hackanson,Christoph Schmid,Udo Holtick,Christof Scheid,Alexandros Spyridonidis,Friedrich Stölzel,Rainer Ordemann,Lutz P Müller,Flore Sicre-de-Fontbrune,Gabriele Ihorst,Jürgen Kuball,Jan E Ehlert,Daniel Feger,Eva-Maria Wagner,Jean-Yves Cahn,Jacqueline Schnell,Florian Kuchenbauer,Donald Bunjes,Ronjon Chakraverty,Simon Richardson,Saar Gill,Nicolaus Kröger,Francis Ayuk,Luca Vago,Fabio Ciceri,Antonia M Müller,Takeshi Kondo,Takanori Teshima,Susan Klaeger,Bernhard Kuster,Dennis (Dong Hwan) Kim,Daniel Weisdorf,Walter van der Velden,Daniela Dörfel,Wolfgang Bethge,Inken Hilgendorf,Andreas Hochhaus,Geoffroy Andrieux,Melanie Börries,Hauke Busch,John Magenau,Pavan Reddy,Myriam Labopin,Joseph H Antin,Andrea S Henden,Geoffrey R Hill,Glen A Kennedy,Merav Bar,Anita Sarma,Donal McLornan,Ghulam Mufti,Betul Oran,Katayoun Rezvani,Omid Shah,Robert S Negrin,Arnon Nagler,Marco Prinz,Andreas Burchert,Andreas Neubauer,Dietrich Beelen,Andreas Mackensen,Nikolas von Bubnoff,Wolfgang Herr,Burkhard Becher,Gerard Socié,Michael A Caligiuri,Eliana Ruggiero,Chiara Bonini,Georg Häcker,Justus Duyster,Jürgen Finke,Erika Pearce,Bruce R Blazar,Robert Zeiser,Dennis Kim

DOI: https://doi.org/10.1038/nm0418-526c

IF: 82.9

2018-04-01

Nature Medicine

Abstract:Nat. Med. 24, 282–291 (2018); published online 12 February 2018; corrected after print 6 March 2018 In the version of this article initially published, Omid Shah's name was misspelled as Omid Sha. The error has been corrected in the PDF and HTML versions of this article.

biochemistry & molecular biology,cell biology,medicine, research & experimental
Publisher Correction: LifeTime and Improving European Healthcare Through Cell-Based Interceptive Medicine

Nikolaus Rajewsky,Geneviève Almouzni,Stanislaw A. Gorski,Stein Aerts,Ido Amit,Michela G. Bertero,Christoph Bock,Annelien L. Bredenoord,Giacomo Cavalli,Susanna Chiocca,Hans Clevers,Bart De Strooper,Angelika Eggert,Jan Ellenberg,Xosé M. Fernández,Marek Figlerowicz,Susan M. Gasser,Norbert Hubner,Jørgen Kjems,Jürgen A. Knoblich,Grietje Krabbe,Peter Lichter,Sten Linnarsson,Jean-Christophe Marine,John C. Marioni,Marc A. Marti-Renom,Mihai G. Netea,Dörthe Nickel,Marcelo Nollmann,Halina R. Novak,Helen Parkinson,Stefano Piccolo,Inês Pinheiro,Ana Pombo,Christian Popp,Wolf Reik,Sergio Roman-Roman,Philip Rosenstiel,Joachim L. Schultze,Oliver Stegle,Amos Tanay,Giuseppe Testa,Dimitris Thanos,Fabian J. Theis,Maria-Elena Torres-Padilla,Alfonso Valencia,Céline Vallot,Alexander van Oudenaarden,Marie Vidal,Thierry Voet,Lavinia Alberi

DOI: https://doi.org/10.1038/s41586-021-03287-8

IF: 64.8

2021-01-01

Nature

Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41586-021-03287-8.
Correction: Srinivasan Rajsri et al. Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection. Cancers 2023, 15, 2866

Kritika Srinivasan Rajsri,Nainita Roy,Sohini Chakraborty

DOI: https://doi.org/10.3390/cancers16050954

2024-02-28

Cancers

Abstract:Cancers, Vol. 16, Pages 954: Correction: Srinivasan Rajsri et al. Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection. Cancers 2023, 15, 2866 Cancers doi: 10.3390/cancers16050954 Authors: Kritika Srinivasan Rajsri Nainita Roy Sohini Chakraborty In the original publication [...]

oncology
Correction: De Sanctis et al. Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event. Cancers 2024, 16, 2630

Juan Bautista De Sanctis,Jenny Valentina Garmendia,Hana Duchová,Viktor Valentini,Alex Puskasu,Agáta Kubíčková,Marián Hajdúch

DOI: https://doi.org/10.3390/cancers16234117

2024-12-10

Cancers

Abstract:Cancers, Vol. 16, Pages 4117: Correction: De Sanctis et al. Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event. Cancers 2024, 16, 2630 Cancers doi: 10.3390/cancers16234117 Authors: Juan Bautista De Sanctis Jenny Valentina Garmendia Hana Duchová Viktor Valentini Alex Puskasu Agáta Kubíčková Marián Hajdúch In the original publication [...]

oncology
Correction: Mazzini et al. Anatomical and Functional Outcomes after Endoresection and Adjuvant Ruthenium Brachytherapy for Uveal Melanoma: A Single-Center Experience. Life 2023, 13, 902

Cinzia Mazzini,Giulio Vicini,Laura Di Leo,Daniela Massi,Stanislao Rizzo,Fabrizio Giansanti

DOI: https://doi.org/10.3390/life14020162

2024-01-23

Life

Abstract:Life, Vol. 14, Pages 162: Correction: Mazzini et al. Anatomical and Functional Outcomes after Endoresection and Adjuvant Ruthenium Brachytherapy for Uveal Melanoma: A Single-Center Experience. Life 2023, 13, 902 Life doi: 10.3390/life14020162 Authors: Cinzia Mazzini Giulio Vicini Laura Di Leo Daniela Massi Stanislao Rizzo Fabrizio Giansanti There was an error in the original publication [...]

biology
Erratum: Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2024.1516456

IF: 4.7

2024-11-06

Frontiers in Oncology

Abstract:This article is an erratum on: Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers

oncology
Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancers 2024, 16, 998

Julia Chisholm,Henry Mandeville,Madeleine Adams,Veronique Minard-Collin,Timothy Rogers,Anna Kelsey,Janet Shipley,Rick R. van Rijn,Isabelle de Vries,Roelof van Ewijk,Bart de Keizer,Susanne A. Gatz,Michela Casanova,Lisa Lyngsie Hjalgrim,Charlotte Firth,Keith Wheatley,Pamela Kearns,Wenyu Liu,Amanda Kirkham,Helen Rees,Gianni Bisogno,Ajla Wasti,Sara Wakeling,Delphine Heenen,Deborah A. Tweddle,Johannes H. M. Merks,Meriel Jenney

DOI: https://doi.org/10.3390/cancers16193427

2024-10-10

Cancers

Abstract:Cancers, Vol. 16, Pages 3427: Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancers 2024, 16, 998 Cancers doi: 10.3390/cancers16193427 Authors: Julia Chisholm Henry Mandeville Madeleine Adams Veronique Minard-Collin Timothy Rogers Anna Kelsey Janet Shipley Rick R. van Rijn Isabelle de Vries Roelof van Ewijk Bart de Keizer Susanne A. Gatz Michela Casanova Lisa Lyngsie Hjalgrim Charlotte Firth Keith Wheatley Pamela Kearns Wenyu Liu Amanda Kirkham Helen Rees Gianni Bisogno Ajla Wasti Sara Wakeling Delphine Heenen Deborah A. Tweddle Johannes H. M. Merks Meriel Jenney The authors wish to make corrections to the authorship and title of [...]

oncology
Molecular Aspects and Therapeutic Perspectives. Int. J. Mol. Sci. 2024, 25, 9023

Luca Guarnera,Matteo D'Addona,Carlos Bravo-Perez,Valeria Visconte

DOI: https://doi.org/10.3390/ijms252111743

IF: 5.6

2024-11-01

International Journal of Molecular Sciences

Abstract:IJMS, Vol. 25, Pages 11743: Correction: Guarnera et al. KMT2A Rearrangements in Leukemias: Molecular Aspects and Therapeutic Perspectives. Int. J. Mol. Sci. 2024, 25, 9023 International Journal of Molecular Sciences doi: 10.3390/ijms252111743 Authors: Luca Guarnera Matteo D'Addona Carlos Bravo-Perez Valeria Visconte There was an error in the original publication [...]

biochemistry & molecular biology,chemistry, multidisciplinary
Corrigendum: Case report: Long remission and survival following immunotherapy in a case of pulmonary pleomorphic carcinoma

Tongshan Wang,Muyang Chen,Anpeng Wang,Hao Zhang

DOI: https://doi.org/10.3389/fimmu.2024.1530843

IF: 7.3

2024-12-03

Frontiers in Immunology

Abstract:This article is a correction to: Case Report: Long Remission and Survival Following Immunotherapy in a Case of Pulmonary Pleomorphic Carcinoma

immunology
Correction: Nelson et al. UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. Cancers 2021, 13, 1566

Ryan S. Nelson,Nathan D. Seligson,Sal Bottiglieri,Estrella Carballido,Alex Del Cueto,Iman Imanirad,Richard Levine,Alexander S. Parker,Sandra M. Swain,Emma M. Tillman,J. Kevin Hicks

DOI: https://doi.org/10.3390/cancers16213595

2024-10-25

Cancers

Abstract:Cancers, Vol. 16, Pages 3595: Correction: Nelson et al. UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. Cancers 2021, 13, 1566 Cancers doi: 10.3390/cancers16213595 Authors: Ryan S. Nelson Nathan D. Seligson Sal Bottiglieri Estrella Carballido Alex Del Cueto Iman Imanirad Richard Levine Alexander S. Parker Sandra M. Swain Emma M. Tillman J. Kevin Hicks In the original publication [...]

oncology
Recent Advances in Material Technology for Leukemia Treatments

Feng Li,Huaiji Wang,Tong Ye,Peilin Guo,Xiaoyun Lin,Yuxing Hu,Wei Wei,Shuang Wang,Guanghui Ma

DOI: https://doi.org/10.1002/adma.202313955

Abstract:Leukemia is a widespread hematological malignancy characterized by an elevated white blood cell count in both the blood and the bone marrow. Despite notable advancements in leukemia intervention in the clinic, a large proportion of patients, especially acute leukemia patients, fail to achieve long-term remission or complete remission following treatment. Therefore, leukemia therapy necessitates optimization to meet the treatment requirements. In recent years, a multitude of materials have undergone rigorous study to serve as delivery vectors or direct intervention agents to bolster the effectiveness of leukemia therapy. These materials include liposomes, protein-based materials, polymeric materials, cell-derived materials, and inorganic materials. They possess unique characteristics and are applied in a broad array of therapeutic modalities, including chemotherapy, gene therapy, immunotherapy, radiotherapy, hematopoietic stem cell transplantation, and other evolving treatments. Here, an overview of these materials is presented, describing their physicochemical properties, their role in leukemia treatment, and the challenges they face in the context of clinical translation. This review inspires researchers to further develop various materials that can be used to augment the efficacy of multiple therapeutic modalities for novel applications in leukemia treatment.
Correction Notice: Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

DOI: https://doi.org/10.1097/HS9.0000000000000987

2023-10-31

HemaSphere

Abstract:[This corrects the article DOI: 10.1097/HS9.0000000000000907.].
Correction: Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia

The PLOS ONE Editors

DOI: https://doi.org/10.1371/journal.pone.0313701

IF: 3.7

2024-11-08

PLoS ONE

Abstract:This article was republished on October 31, 2024, to address an issue identified post-publication and provide an updated version of S1 File. Please download this article again to view the correct version.

multidisciplinary sciences
Erratum: "Toward improved models of human cancer" [APL Bioeng. 5, 010901 (2021)]

Bryan E Welm,Christos Vaklavas,Alana L Welm

DOI: https://doi.org/10.1063/5.0057199

2021-06-02

Abstract:[This corrects the article DOI: 10.1063/5.0030534.].
Erratum: Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics [Corrigendum]

DOI: https://doi.org/10.2147/IJN.S500182

2024-10-14

Abstract:[This corrects the article DOI: 10.2147/IJN.S448556.].
Author Correction: Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer

Jacqulyne P. Robichaux,Yasir Y. Elamin,Zhi Tan,Brett W. Carter,Shuxing Zhang,Shengwu Liu,Shuai Li,Ting Chen,Alissa Poteete,Adriana Estrada-Bernal,Anh T. Le,Anna Truini,Monique B. Nilsson,Huiying Sun,Emily Roarty,Sarah B. Goldberg,Julie R. Brahmer,Mehmet Altan,Charles Lu,Vassiliki Papadimitrakopoulou,Katerina Politi,Robert C. Doebele,Kwok-Kin Wong,John V. Heymach

DOI: https://doi.org/10.1038/s41591-024-03178-1

IF: 82.9

2024-08-22

Nature Medicine

Abstract:Nature Medicine, Published online: 20 August 2024; doi:10.1038/s41591-024-03178-1 Author Correction: Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer

biochemistry & molecular biology,cell biology,medicine, research & experimental
Correction: Catalase-like Metal–organic Framework Nanoparticles to Enhance Radiotherapy in Hypoxic Cancer and Prevent Cancer Recurrence

Yuanyuan Chen,Hui Zhong,Jianbo Wang,Xiuyan Wan,Yanhua Li,Wei Pan,Na Li,Bo Tang

DOI: https://doi.org/10.1039/d0sc90108c

IF: 8.4

2020-01-01

Chemical Science

Abstract:Correction for ‘Catalase-like metal–organic framework nanoparticles to enhance radiotherapy in hypoxic cancer and prevent cancer recurrence’ by Yuanyuan Chen et al., Chem. Sci., 2019, 10, 5773–5778, DOI: 10.1039/C9SC00747D.

Correction: To Mars and beyond. Space exploration and space medicine in Leukemia

To Mars and beyond. Space exploration and space medicine in Leukemia

Author Correction: Decade-long leukaemia remissions with persistence of CD4 + CAR T cells

Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases10 (2023) 1367–1401]

Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Publisher Correction: LifeTime and Improving European Healthcare Through Cell-Based Interceptive Medicine

Correction: Srinivasan Rajsri et al. Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection. Cancers 2023, 15, 2866

Correction: De Sanctis et al. Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event. Cancers 2024, 16, 2630

Correction: Mazzini et al. Anatomical and Functional Outcomes after Endoresection and Adjuvant Ruthenium Brachytherapy for Uveal Melanoma: A Single-Center Experience. Life 2023, 13, 902

Erratum: Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers

Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancers 2024, 16, 998

Molecular Aspects and Therapeutic Perspectives. Int. J. Mol. Sci. 2024, 25, 9023

Corrigendum: Case report: Long remission and survival following immunotherapy in a case of pulmonary pleomorphic carcinoma

Correction: Nelson et al. UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. Cancers 2021, 13, 1566

Recent Advances in Material Technology for Leukemia Treatments

Correction Notice: Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

Correction: Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia

Erratum: "Toward improved models of human cancer" [APL Bioeng. 5, 010901 (2021)]

Erratum: Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics [Corrigendum]

Author Correction: Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer

Correction: Catalase-like Metal–organic Framework Nanoparticles to Enhance Radiotherapy in Hypoxic Cancer and Prevent Cancer Recurrence